person

Marcel N.

Country
The Netherlands
Department
Hematology

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
148
Sites with multiple studies

Has run more than one trial at 148 of 299 partner sites.

Specializations

B-Cell Lymphoma Expertise

The investigator specializes in treating various forms of B-cell lymphomas, with particular focus on diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma. Their research encompasses both newly diagnosed cases and relapsed/refractory conditions.

  • High-risk DLBCL management
  • Novel combination therapies
  • Molecular imaging techniques

They demonstrate expertise in innovative therapeutic approaches using targeted antibody treatments and immunotherapy combinations.

Chronic Lymphocytic Disorders

The investigator focuses on treating chronic lymphocytic leukemia and associated conditions, including Richter's syndrome. Their work involves evaluating novel therapeutic combinations and treatment strategies for resistant disease.

  • Targeted therapy approaches
  • Combination treatment protocols
  • Management of refractory disease

Their research includes investigating innovative antibody-based treatments and their combinations with established therapies.

Advanced Therapeutic Development

The investigator works with cutting-edge treatments including monoclonal antibodies and targeted molecular therapies. Their research involves evaluating novel therapeutic agents and combinations for various lymphoid malignancies.

  • Immunotherapy development
  • Treatment resistance studies
  • Clinical efficacy assessment

Their work includes investigating biomarker-driven approaches and personalized treatment strategies.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.